Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India.
Location: India, Gujarat, Sarkhej
Employees: 5001-10000
Phone: +91 79 3983 7000
Total raised: $56.2M
Founded date: 1976
Investors 1
| Date | Name | Website |
| - | ChrysCapit... | chryscapit... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.05.2012 | - | $56.2M | ChrysCapit... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 29.04.2024 | Henlius Trastuzumab Receives FDA Approval in the United Stat... | SHANGHAI, April 29, 2024 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the... | en.prnasia... |
| 21.03.2024 | Henlius 2023 Annual Results: Revenue surpassed RMB5.39 billi... | SHANGHAI, March 21, 2024 /PRNewswire/ -- Henlius (2696.HK) announced its 2023 annual results. During... | en.prnasia... |
| 22.07.2021 | Intas Enters into an Exclusive License Agreement with Meiji ... | Intas Pharmaceuticals Ltd continues to pledge their commitment to increasing access to high quality ... | en.prnasia... |
| 04.03.2021 | Foresee Pharmaceuticals Enters Exclusive License Agreement w... | TAIPEI, March 4, 2021 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO) ("Foresee") annou... | oaoa.com/n... |
| 12.05.2012 | ChrysCapital Invests $56.2M In Intas Pharmaceuticals | Private equity major ChrysCapital is investing Rs 300 crore ($56.2 million) in Ahmedabad-based Intas... | vccircle.c... |